BRS5-FM3-PM8 — Neurotransmitter Precursor Biotransformation & Availability
Stage 2B draft — not approved. Independent Stage 2A/2B review. Canonical science, mappings and review status are unchanged.
1. Mission & Overview
Mission
Maintain gut-side processing that shapes neurotransmitter precursor availability.
Intervention Dominance: Diet-Supported — Dietary Requirements
- Tryptophan
- Apple pectin (studied preparation)
- Pyridoxal 5′-phosphate (PLP; active vitamin B6 cofactor)
- Fermentable fibre resource pool
Overview
Gut microbes share substrates and compete for amino acids. Their processing can divert tryptophan into different metabolites before the host uses it. A tested pectin exposure redirected that processing in microbial communities and mice. These results explain gut-side precursor handling; they do not establish more brain serotonin, dopamine or better cognition. [2]
- Benefits: Maintaining appropriate gut-side precursor handling may influence the molecules available to the host. Benefits for brain neurotransmission remain unestablished by the processing experiments.
- Implementation Notes: Tryptophan supplies the studied microbial reactions. Apple pectin changed competing routes in the tested systems; neither result justifies a general protein, vitamin or plant-diversity checklist.
- Biological Relevance: Microbial metabolites, host precursor pools, blood–brain transport and neuronal synthesis are separate steps. Predicted genes are not measured enzyme activity or precursor delivery.
2. Primary Biological Effects
- A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism. [2]
- E. coli tryptophanase contains bound pyridoxal 5′-phosphate in its holo structure. [6]
3. Intervention Levers
No separately adjudicated practice is admitted in this bounded draft. This is not evidence that no practice can affect the mechanism.
No separately adjudicated lifestyle lever is admitted in this bounded draft.
4. Mechanistic Basis
Summary
A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism. [2]
Biological process
The immediate substrate is tryptophan, and the defined carbohydrate exposure affects microbial processing; neither establishes central neurotransmitter benefit. [2]
Mechanism Boundary
Microbial metabolites, host precursor pools, blood–brain transport and neuronal synthesis are separate steps. Predicted genes are not measured enzyme activity or precursor delivery.
Integration
This PM contributes its specific process to its parent FM. Shared inputs do not merge distinct jobs or prove an integrated clinical outcome.
4.1 Scientific Findings
Summary
Pectin experiments connect microbial cross-feeding, tryptophanase repression and altered tryptophan metabolites. Structural evidence confirms the enzyme’s PLP cofactor. Human taxonomic/reward associations do not establish precursor flux or clinical benefit. [2] [1] [6]
A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism.
What this means
The immediate substrate is tryptophan, and the defined carbohydrate exposure affects microbial processing; neither establishes central neurotransmitter benefit.
Evidence confidence: Not yet scored
Finding ID: PM8-F1
Finding Statement: A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The immediate substrate is tryptophan, and the defined carbohydrate exposure affects microbial processing; neither establishes central neurotransmitter benefit.
Synthesis Limitations: Culture, human-derived faecal communities and mouse results are not human brain precursor-flux measurements.
Evidence Considered:
- Study
- Defined cultures, human-derived faecal communities and humanised mice with apple pectin.
- Population
- Defined cultures, human-derived faecal communities and humanised mice with apple pectin.
- Result
- Carbohydrate cross-feeding repressed E. coli tryptophanase and shifted tryptophan metabolites, including routes involving C. sporogenes.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Carbohydrate cross-feeding repressed E. coli tryptophanase and shifted tryptophan metabolites, including routes involving C. sporogenes.
- Limitations
- Preserve tested preparation and systems; metabolite changes do not show brain tryptophan entry or serotonin synthesis.
- Evidence Source
- Bounded external search
- Reference
- [2]
- Study
- Attached review of host/microbial tryptophan pathways.
- Population
- Attached review of host/microbial tryptophan pathways.
- Result
- Multiple competing routes and compartments connect gut tryptophan handling with host physiology.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Multiple competing routes and compartments connect gut tryptophan handling with host physiology.
- Limitations
- Review context is not a food intervention or measured neuronal outcome.
- Evidence Source
- Bounded external search
- Reference
- [1]
Connected / Supportive Evidence:
- Jiang et al. (2018) [3]Why relevant: Attached corpus assessed for connection to this PM; preserved in the draft evidence inventory.Why excluded from the primary synthesis: Taxonomic/symptom association; does not measure the PM’s microbial effector, barrier, nerve or precursor flux.
- Steckler et al. (2024) [4]Why relevant: Attached corpus assessed for connection to this PM; preserved in the draft evidence inventory.Why excluded from the primary synthesis: Cross-sectional faecal SCFAs and microbiota; concentration is not synthesis flux, causal mediation or a treatment outcome.
- Aarts et al. (2017) [5]Why relevant: Attached corpus assessed for connection to this PM; preserved in the draft evidence inventory.Why excluded from the primary synthesis: Predicted phenylalanine-pathway potential and reward-imaging association; not measured precursor flux, absorption or neural delivery.
E. coli tryptophanase contains bound pyridoxal 5′-phosphate in its holo structure.
What this means
The enzyme’s cofactor role is established; dietary vitamin B6 limitation of this microbial route is not established.
Evidence confidence: Not yet scored
Finding ID: PM8-F2
Finding Statement: E. coli tryptophanase contains bound pyridoxal 5′-phosphate in its holo structure.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The enzyme’s cofactor role is established; dietary vitamin B6 limitation of this microbial route is not established.
Synthesis Limitations: Microbial cofactor synthesis, availability and host delivery must be assessed separately.
Evidence Considered:
- Study
- Crystallographic comparison of E. coli holo and semi-holo tryptophanase.
- Population
- Crystallographic comparison of E. coli holo and semi-holo tryptophanase.
- Result
- Holo enzyme contained PLP bound to the active-site lysine, with conformation differences from apo enzyme.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Holo enzyme contained PLP bound to the active-site lysine, with conformation differences from apo enzyme.
- Limitations
- Structural dependency does not establish that host vitamin B6 intake limits microbial activity.
- Evidence Source
- Bounded external search
- Reference
- [6]
5. BRS Pathways and Connections
5.1 BRS Pathways
No newly adjudicated pathway is added by this preview.
5.2 Cross-BRS Mechanism Relationships
Existing connected mechanisms remain candidates in the review history; no new downstream admission is inferred.
5.3 Local BRS Mechanism Relationships
- BRS5-FM2-PM4 — Microbial Substrate-Processing Selection & Adaptation: related process for scope comparison; this link does not admit a newly characterised dependency.
- BRS5-FM3-PM7 — Vagal / ENS Signalling Modulation: related process for scope comparison; this link does not admit a newly characterised dependency.
7. Phenome Connections
No new phenome rating or outcome admission is made in this unapproved draft. Inherited candidate relationships are preserved in the assessment record; microbial, cellular and animal findings do not automatically establish a human cognitive effect.
8. References
- [1] O'Mahony et al. (2015) — Serotonin, Tryptophan Metabolism and the Brain-gut-microbiome Axis
- [2] Sinha et al. (2024) — Dietary Fibre Directs Microbial Tryptophan Metabolism via Metabolic Interactions in the Gut
- [3] Jiang et al. (2018) — Gut Microbiota Profiles in Treatment-naïve Children with Attention Deficit Hyperactivity Disorder
- [4] Steckler et al. (2024) — Dysbiosis and Decreased Short-chain Fatty Acids
- [5] Aarts et al. (2017) — Gut Microbiome in ADHD and Its Relation to Neural Reward Anticipation
- [6] Kogan et al. (2015) — Structures of Escherichia coli tryptophanase in holo and semi-holo forms